Fujian Aonong Biological Technology Group Incorporation Ltd Net Assets
Fujian Aonong Biological Technology Group Incorporation Ltd net assets. Based on the latest financial reports, Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has net assets worth CN¥3.34 Billion CNY (≈ $489.04 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥8.81 Billion ≈ $1.29 Billion USD) and total liabilities (CN¥5.47 Billion ≈ $800.59 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Fujian Aonong Biological Technology Grou growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.34 Billion |
| % of Total Assets | 37.92% |
| Annual Growth Rate | 34.05% |
| 5-Year Change | 63.26% |
| 10-Year Change | 502.98% |
| Growth Volatility | 79.2 |
Net Assets of Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)
Net assets of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025. This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's net assets have evolved over time, based on quarterly financial data. See 603363 net asset quality score to measure how much of total assets are equity-financed.
Annual Net Assets for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)
The table below shows the annual net assets of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025. For live market cap and overall valuation, see 603363 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.58 Billion ≈ $523.90 Million |
+16.96% |
| 2024-12-31 | CN¥3.06 Billion ≈ $447.94 Million |
+708.32% |
| 2023-12-31 | CN¥-503.22 Million ≈ $-73.64 Million |
-114.66% |
| 2022-12-31 | CN¥3.43 Billion ≈ $502.21 Million |
+56.50% |
| 2021-12-31 | CN¥2.19 Billion ≈ $320.90 Million |
-43.82% |
| 2020-12-31 | CN¥3.90 Billion ≈ $571.16 Million |
+204.09% |
| 2019-12-31 | CN¥1.28 Billion ≈ $187.83 Million |
+27.22% |
| 2018-12-31 | CN¥1.01 Billion ≈ $147.64 Million |
+4.49% |
| 2017-12-31 | CN¥965.55 Million ≈ $141.29 Million |
+62.62% |
| 2016-12-31 | CN¥593.75 Million ≈ $86.88 Million |
+33.31% |
| 2015-12-31 | CN¥445.39 Million ≈ $65.17 Million |
+107.21% |
| 2014-12-31 | CN¥214.94 Million ≈ $31.45 Million |
+102.10% |
| 2013-12-31 | CN¥106.35 Million ≈ $15.56 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Fujian Aonong Biological Technology Group Incorporation Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 28530.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Fujian Aonong Biological Technology Group Incorporation Ltd Net Assets Breakdown (December 2025)
Fujian Aonong Biological Technology Group Incorporation Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥8.10 Billion | 258.66% |
| Total Equity | CN¥3.13 Billion | 100.00% |
Fujian Aonong Biological Technology Group Incorporation Ltd Competitors by Market Cap
The table below lists competitors of Fujian Aonong Biological Technology Group Incorporation Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PNC Process Systems Co Ltd
SHG:603690
|
$1.08 Billion |
|
Scientech Corp
TW:3583
|
$1.08 Billion |
|
Ratos AB (publ)
ST:RATO-B
|
$1.08 Billion |
|
Shanghai Taisheng Wind Power
SHE:300129
|
$1.08 Billion |
|
Zhejiang Taihua New Material
SHG:603055
|
$1.07 Billion |
|
NanJi ECommerce Co Ltd
SHE:002127
|
$1.07 Billion |
|
Fuxin Dare Automotive Parts Co Ltd
SHE:300473
|
$1.07 Billion |
|
Lindab International AB
ST:LIAB
|
$1.07 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fujian Aonong Biological Technology Group Incorporation Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,566,181,540 to 3,130,473,782, a change of 564,292,242 (22.0%).
- Net income of 77,621,595 contributed positively to equity growth.
- Dividend payments of 84,505,769 reduced retained earnings.
- Other comprehensive income decreased equity by 95,985,620.
- Other factors increased equity by 667,162,036.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥77.62 Million | +2.48% |
| Dividends Paid | CN¥84.51 Million | -2.7% |
| Other Comprehensive Income | CN¥-95.99 Million | -3.07% |
| Other Changes | CN¥667.16 Million | +21.31% |
| Total Change | CN¥- | 21.99% |
Book Value vs Market Value Analysis
This analysis compares Fujian Aonong Biological Technology Group Incorporation Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.24x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 12.62x to 2.24x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥0.21 | CN¥2.69 | x |
| 2014-12-31 | CN¥0.39 | CN¥2.69 | x |
| 2015-12-31 | CN¥0.79 | CN¥2.69 | x |
| 2016-12-31 | CN¥1.00 | CN¥2.69 | x |
| 2017-12-31 | CN¥1.67 | CN¥2.69 | x |
| 2018-12-31 | CN¥1.45 | CN¥2.69 | x |
| 2019-12-31 | CN¥1.52 | CN¥2.69 | x |
| 2020-12-31 | CN¥4.35 | CN¥2.69 | x |
| 2021-12-31 | CN¥2.37 | CN¥2.69 | x |
| 2022-12-31 | CN¥3.23 | CN¥2.69 | x |
| 2023-12-31 | CN¥-1.11 | CN¥2.69 | x |
| 2024-12-31 | CN¥2.97 | CN¥2.69 | x |
| 2025-12-31 | CN¥1.20 | CN¥2.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fujian Aonong Biological Technology Group Incorporation Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.48%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.92%
- • Asset Turnover: 0.97x
- • Equity Multiplier: 2.79x
- Recent ROE (2.48%) is above the historical average (-0.89%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 26.69% | 0.85% | 4.16x | 7.59x | CN¥15.63 Million |
| 2014 | 25.05% | 1.02% | 4.51x | 5.43x | CN¥25.68 Million |
| 2015 | 8.86% | 0.84% | 2.98x | 3.54x | CN¥-4.33 Million |
| 2016 | 19.31% | 1.84% | 2.91x | 3.62x | CN¥44.06 Million |
| 2017 | 13.37% | 2.21% | 1.93x | 3.14x | CN¥27.27 Million |
| 2018 | 3.70% | 0.52% | 1.74x | 4.06x | CN¥-51.25 Million |
| 2019 | 3.52% | 0.50% | 1.18x | 5.94x | CN¥-53.65 Million |
| 2020 | 20.90% | 4.98% | 0.96x | 4.38x | CN¥298.78 Million |
| 2021 | -116.60% | -8.43% | 1.05x | 13.12x | CN¥-1.65 Billion |
| 2022 | -41.47% | -4.80% | 1.16x | 7.45x | CN¥-1.29 Billion |
| 2023 | 0.00% | -18.76% | 1.43x | 0.00x | CN¥-3.55 Billion |
| 2024 | 22.58% | 6.61% | 0.92x | 3.70x | CN¥322.73 Million |
| 2025 | 2.48% | 0.92% | 0.97x | 2.79x | CN¥-235.43 Million |
Industry Comparison
This section compares Fujian Aonong Biological Technology Group Incorporation Ltd's net assets metrics with peer companies in the Farm Products industry.
Industry Context
- Industry: Farm Products
- Average net assets among peers: $1,317,147,078
- Average return on equity (ROE) among peers: 7.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fujian Aonong Biological Technology Group Incorporation Ltd (603363) | CN¥3.34 Billion | 26.69% | 1.64x | $1.08 Billion |
| ShenZhen Kondarl Group Co Ltd (000048) | $82.08 Million | -109.08% | 15.62x | $1.07 Billion |
| Guangdong Guanghong Holdings Co Ltd (000529) | $1.27 Billion | 12.42% | 0.81x | $393.82 Million |
| Hunan Zhenghong Science and Technology Develop Co Ltd (000702) | $461.02 Million | 0.44% | 0.40x | $253.61 Million |
| Hefei Fengle Seed Co Ltd (000713) | $654.50 Million | 0.90% | 0.41x | $648.27 Million |
| Luoniushan Co Ltd (000735) | $4.09 Billion | 9.50% | 0.54x | $854.31 Million |
| New Hope Liuhe Co Ltd (000876) | $50.09 Million | 71.65% | 0.44x | $4.67 Billion |
| Yuan Longping High-tech Agriculture Co Ltd (000998) | $1.64 Billion | 10.42% | 1.19x | $1.75 Billion |
| Dongrui Food Group Co Ltd (001201) | $1.20 Billion | 56.67% | 0.45x | $613.36 Million |
| Jiangxi Sunshine Dairy Co Ltd (001318) | $581.46 Million | 18.05% | 0.28x | $545.98 Million |
| Shandong Denghai Seeds Co Ltd (002041) | $3.14 Billion | 3.25% | 0.20x | $1.16 Billion |
About Fujian Aonong Biological Technology Group Incorporation Ltd
Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig farming, food, supply chain services, and other businesses in China and internationally. It researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant, and other products; and operates pig breeding farms. The company also engages in the pig slaughtering … Read more